128 related articles for article (PubMed ID: 15657824)
1. [Potential advantages of the MRI for the radiofrequency ablation of liver tumors].
Gaffke G; Gebauer B; Gnauck M; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
Rofo; 2005 Jan; 177(1):77-83. PubMed ID: 15657824
[TBL] [Abstract][Full Text] [Related]
2. Use of semiflexible applicators for radiofrequency ablation of liver tumors.
Gaffke G; Gebauer B; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
Cardiovasc Intervent Radiol; 2006; 29(2):270-5. PubMed ID: 16328685
[TBL] [Abstract][Full Text] [Related]
3. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
4. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
5. [Flexible applicator systems for radiofrequency ablation (RFA) of hepatic tumors].
Gebauer B; Gaffke G; Hünerbein M; Felix R; Stroszczynski C
Rofo; 2003 Dec; 175(12):1720-3. PubMed ID: 14661145
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
[TBL] [Abstract][Full Text] [Related]
7. Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results.
Bruners P; Schmitz-Rode T; Günther RW; Mahnken A
Rofo; 2008 Mar; 180(3):216-22. PubMed ID: 18278730
[TBL] [Abstract][Full Text] [Related]
8. Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept.
Ritz JP; Lehmann KS; Reissfelder C; Albrecht T; Frericks B; Zurbuchen U; Buhr HJ
Int J Colorectal Dis; 2006 Jan; 21(1):25-32. PubMed ID: 15875202
[TBL] [Abstract][Full Text] [Related]
9. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL
Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
[TBL] [Abstract][Full Text] [Related]
10. MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors.
Clasen S; Boss A; Schmidt D; Schraml C; Fritz J; Schick F; Claussen CD; Pereira PL
J Magn Reson Imaging; 2007 Oct; 26(4):1043-52. PubMed ID: 17896364
[TBL] [Abstract][Full Text] [Related]
11. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance-guided freehand radiofrequency ablation of malignant liver lesions: a new simplified and time-efficient approach using an interactive open magnetic resonance scan platform and hepatocyte-specific contrast agent.
Fischbach F; Lohfink K; Gaffke G; Wybranski C; Mohnike K; Wonneberger U; Pech M; Jungnickel K; Ricke J; Strach K
Invest Radiol; 2013 Jun; 48(6):422-8. PubMed ID: 23399808
[TBL] [Abstract][Full Text] [Related]
13. Factors limiting complete tumor ablation by radiofrequency ablation.
Paulet E; Aubé C; Pessaux P; Lebigot J; Lhermitte E; Oberti F; Ponthieux A; Calès P; Ridereau-Zins C; Pereira PL
Cardiovasc Intervent Radiol; 2008; 31(1):107-15. PubMed ID: 17968620
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
15. Role of B-mode ultrasound screening in detection of local tumor recurrence in the first year after radiofrequency ablation in the liver.
Eisele RM; Schumacher G; Lopez-Hänninen E; Neuhaus P
Cancer Detect Prev; 2007; 31(4):316-22. PubMed ID: 17935909
[TBL] [Abstract][Full Text] [Related]
16. [Percutaneous radiofrequency ablation of liver malignancies: first experience with a 200-W radiofrequency generator].
Mahnken AH; Tacke J; Bücker A; Günther RW
Rofo; 2002 Feb; 174(2):216-23. PubMed ID: 11898085
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of different magnetic resonance imaging sequences for detecting local tumor progression after radiofrequency ablation of hepatic malignancies.
Weiss J; Rempp H; Clasen S; Notohamiprodjo M; Keßler DE; Pereira PL; Blumenstock G; Nikolaou K; Hoffmann R
Eur J Radiol; 2017 Sep; 94():85-92. PubMed ID: 28655432
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation.
Schindera ST; Nelson RC; DeLong DM; Clary B
J Vasc Interv Radiol; 2006 Oct; 17(10):1631-7. PubMed ID: 17057005
[TBL] [Abstract][Full Text] [Related]
19. In vitro artefact assessment of a new MR-compatible microwave antenna and a standard MR-compatible radiofrequency ablation electrode for tumour ablation.
Hoffmann R; Rempp H; Eibofner F; Keßler DE; Blumenstock G; Weiß J; Pereira PL; Nikolaou K; Clasen S
Eur Radiol; 2016 Mar; 26(3):771-9. PubMed ID: 26134999
[TBL] [Abstract][Full Text] [Related]
20. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
